DE68905633D1 - Markierer der t-zelle aktivierung. - Google Patents

Markierer der t-zelle aktivierung.

Info

Publication number
DE68905633D1
DE68905633D1 DE8989301341T DE68905633T DE68905633D1 DE 68905633 D1 DE68905633 D1 DE 68905633D1 DE 8989301341 T DE8989301341 T DE 8989301341T DE 68905633 T DE68905633 T DE 68905633T DE 68905633 D1 DE68905633 D1 DE 68905633D1
Authority
DE
Germany
Prior art keywords
cells
activated
cell activation
activation marker
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989301341T
Other languages
English (en)
Other versions
DE68905633T2 (de
Inventor
Keith D Brown
Timothy R Mosmann
Gerald Zurawski
Sandra M Zurawski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Application granted granted Critical
Publication of DE68905633D1 publication Critical patent/DE68905633D1/de
Publication of DE68905633T2 publication Critical patent/DE68905633T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
DE8989301341T 1988-02-18 1989-02-13 Markierer der t-zelle aktivierung. Expired - Fee Related DE68905633T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/157,743 US5001230A (en) 1988-02-18 1988-02-18 T cell activation markers

Publications (2)

Publication Number Publication Date
DE68905633D1 true DE68905633D1 (de) 1993-05-06
DE68905633T2 DE68905633T2 (de) 1993-07-08

Family

ID=22565071

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989301341T Expired - Fee Related DE68905633T2 (de) 1988-02-18 1989-02-13 Markierer der t-zelle aktivierung.

Country Status (9)

Country Link
US (1) US5001230A (de)
EP (2) EP0329363B1 (de)
JP (1) JP2910861B2 (de)
AT (1) ATE87655T1 (de)
AU (1) AU3192889A (de)
CA (1) CA1340869C (de)
DE (1) DE68905633T2 (de)
ES (1) ES2046462T3 (de)
WO (1) WO1989007646A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705612A (en) * 1984-10-18 1998-01-06 Institut Pasteur And Centre National De La Recherche Scientifique NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
AU582288B2 (en) * 1986-03-07 1989-03-16 Damon Biotech Inc. Vector and method for achieving high level expression in eukaryotic cells
US5637488A (en) * 1987-06-01 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services HIV protease gene and method for its expression
DE3878468T2 (de) * 1987-12-23 1993-06-09 Upjohn Co Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
JPH04503300A (ja) * 1988-10-06 1992-06-18 デイナ・フアーバー・キヤンサー・インステイテユート Ｈ．ｓａｉｍｉｒｉ―ｈｔｌｖ―ｘ領域ベクター
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them
JP2903414B2 (ja) * 1989-05-31 1999-06-07 味の素株式会社 抗酸菌分泌発現ベクター及び抗酸菌
ES2150188T3 (es) * 1989-07-07 2000-11-16 Unilever Nv Procedimiento para la preparacion de una proteina mediante un hongo transformado por integracion multicopia de un vector de expresion.
US6004776A (en) * 1989-07-07 1999-12-21 Unilever Patent Holdings, B.V. Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector
AU649228B2 (en) * 1989-07-28 1994-05-19 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Efficient directional genetic cloning system
US5541083A (en) * 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
FR2656800B1 (fr) * 1990-01-08 1992-05-15 Roussy Inst Gustave Nouvelles proteines produits par les lymphocytes humains, sequence d'adn codant pour ces proteines et applications pharmaceutiques et biologiques.
US5976877A (en) * 1990-01-08 1999-11-02 Institut National De La Sante Et De La Recherche Medicale (Inserm) Proteins produced by human lymphocytes DNA sequence encoding these proteins and their pharmaceutical and biological uses
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5413927A (en) * 1991-09-03 1995-05-09 North Carolina State University Feline immunodeficiency virus isolate NCSU1Lb
WO1993011244A1 (en) * 1991-11-29 1993-06-10 Weyerhaeuser Company Cyclic di-guanylate metabolic enzymes
TW318189B (de) * 1991-12-06 1997-10-21 American Cyanamid Co
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
IL108707A (en) * 1993-02-19 1999-06-20 Weiner David B Pharmaceutical compositions and diagnostic kits containing RPH protein or RPV-binding proteins
US5597707A (en) * 1993-04-15 1997-01-28 Bristol-Myers Squibb Company Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use
AU1373395A (en) * 1993-12-15 1995-07-03 Trustees Of The University Of Pennsylvania, The Vpr receptor protein
US5653686A (en) * 1995-01-13 1997-08-05 Coulter Corporation Closed vial transfer method and system
US6087486A (en) * 1996-01-29 2000-07-11 The Trustees Of The University Of Pennsylvania Nucleotide sequences encoding vpr receptor protein
US6060587A (en) 1996-01-29 2000-05-09 The Trustees Of The University Of Pennsylvania Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
WO1998054226A1 (en) * 1997-05-29 1998-12-03 New Zealand Pastoral Agriculture Research Institute Limited Processes for production of immunoglobulin a in milk
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
US6087128A (en) * 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
US6448078B1 (en) 1998-10-09 2002-09-10 The Trustees Of The University Of Pennsylvania Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle
CA2376245A1 (en) * 1999-07-29 2001-02-08 Dyax Corp. Binding moieties for fibrin
TWI240632B (en) 2001-07-30 2005-10-01 Epix Medical Inc Purified peptides for peptide-based multimeric targeted contrast agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4483920A (en) * 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
EP0194626A3 (de) * 1985-03-15 1988-05-18 Sloan-Kettering Institute For Cancer Research Verfahren zur Transformation und direkten Selektion von Transformanten in eukaryotischen Zellen
US4788137A (en) * 1985-10-29 1988-11-29 Dana-Farber Cancer Institute, Inc. Detection of activated T-cells
DE3650184T2 (de) * 1985-12-03 1995-05-11 T Cell Sciences Inc Zellenfreier t-zellenantigenrezeptor und klinische verwendung.
DE260880T1 (de) * 1986-09-11 1988-11-03 Dana-Farber Cancer Institute, Inc., Boston, Mass., Us Verfahren zur ausloesung der zytotoxizitaet.

Also Published As

Publication number Publication date
US5001230A (en) 1991-03-19
JP2910861B2 (ja) 1999-06-23
EP0415930A1 (de) 1991-03-13
ES2046462T3 (es) 1994-02-01
EP0329363A1 (de) 1989-08-23
JPH03504316A (ja) 1991-09-26
ATE87655T1 (de) 1993-04-15
EP0329363B1 (de) 1993-03-31
DE68905633T2 (de) 1993-07-08
CA1340869C (en) 2000-01-04
WO1989007646A1 (en) 1989-08-24
AU3192889A (en) 1989-09-06

Similar Documents

Publication Publication Date Title
DE68905633T2 (de) Markierer der t-zelle aktivierung.
DK110885A (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
CH0229046H1 (de) Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
FI873141A0 (fi) Daeggdjurs interleukin-4.
FI961251A (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
ES2064355T3 (es) Procedimiento para cultivar celulas recombinantes.
DK374087A (da) Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
NL300197I1 (de)
ATE296348T1 (de) Cytokin lerk-7
NO995458D0 (no) Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder
ATE47155T1 (de) Monoklonaler antikoerper.
EP0149548A3 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
DK1032672T3 (da) DNA19355-polypeptid, en tumornekrosefaktor-homolog
ES2059330T3 (es) Un cdna codificador de antigeno carcinoembrionico.
DE3671043D1 (de) Ueberbrueckungsschalter fuer membranzelle.
EP0293827A3 (de) Probe für Leishmaniosis
NO853400L (no) Polypeptidvaksiner.
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DK48890D0 (da) Nukleinsyre, der koder for toxoplasma gondii p30 proteinet
NO894573D0 (no) Rekombinante interleukin-2 hybridproteiner.
DE68906167T2 (de) Zusammensetzung zur erkennung von paradontalen krankheiten.
DE3576856D1 (de) Schutzloesung fuer stabilisierte vogelerythrozyten zur verwendung bei der virushaemagglutinierungsprobe.
DE3685636D1 (de) Lysozymbetreffende peptide.
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING CORP., KENILWORTH, N.J., US

8339 Ceased/non-payment of the annual fee